China Literature Ltd
HKEX:772

Watchlist Manager
China Literature Ltd Logo
China Literature Ltd
HKEX:772
Watchlist
Price: 29.7 HKD -7.33%
Updated: May 20, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

23.2B
+4%
Assets
Growth Rates:
1 Year
+2%
3 Years
+9%
5 Years
-17%
7 Years
-
10 Years
-
4.2B
+9%
Liabilities
Growth Rates:
1 Year
-13%
3 Years
-33%
5 Years
-56%
7 Years
-
10 Years
-
19B
+2%
Equity
Growth Rates:
1 Year
+6%
3 Years
+26%
5 Years
+3%
7 Years
-
10 Years
-

Balance Sheet Decomposition
China Literature Ltd

23.2B
Assets
4.2B
Liabilities
23.2B
Assets
4.2B
Liabilities
Current Assets 11.2B
Cash & Short-Term Investments 6.3B
Receivables 3B
Other Current Assets 2B
Non-Current Assets 12B
Long-Term Investments 3.6B
PP&E 336m
Intangibles 7.3B
Other Non-Current Assets 685.7m
Current Liabilities 3.6B
Accounts Payable 1.1B
Accrued Liabilities 648.4m
Short-Term Debt 10m
Other Current Liabilities 1.8B
Non-Current Liabilities 560.4m
Long-Term Debt 401m
Other Non-Current Liabilities 159.4m

Balance Sheet
China Literature Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
830
331
405
7 502
8 342
5 932
2 848
4 528
5 546
2 802
Cash Equivalents
830
331
405
7 502
8 342
5 932
2 848
4 528
5 546
2 802
Short-Term Investments
74
297
368
653
508
416
3 409
2 678
1 968
3 481
Total Receivables
243
509
1 096
977
2 131
3 635
3 624
3 337
2 907
2 954
Accounts Receivables
226
178
550
760
1 830
3 366
3 296
2 747
2 048
1 988
Other Receivables
16
331
546
217
301
269
328
590
859
966
Inventory
153
148
138
222
2 987
1 714
1 212
1 745
1 701
1 739
Other Current Assets
60
70
108
79
309
494
407
442
355
247
Total Current Assets
1 360
1 355
2 115
9 434
14 278
12 191
11 500
12 730
12 476
11 223
PP&E Net
29
37
45
36
48
134
123
327
316
336
PP&E Gross
29
37
45
36
0
0
0
0
0
0
Accumulated Depreciation
0
13
18
36
0
0
0
0
0
0
Intangible Assets
1 188
1 094
966
781
1 488
1 515
1 039
823
789
697
Goodwill
3 716
3 726
3 716
3 720
10 653
10 653
6 637
6 633
6 633
6 633
Note Receivable
0
0
0
0
0
0
0
0
0
29
Long-Term Investments
46
115
234
1 085
1 125
1 421
1 514
2 256
1 879
3 614
Other Long-Term Assets
44
53
56
81
243
336
503
529
642
656
Other Assets
3 716
3 726
3 716
3 720
10 653
10 653
6 637
6 633
6 633
6 633
Total Assets
6 383
N/A
6 381
0%
7 132
+12%
15 137
+112%
27 835
+84%
26 250
-6%
21 316
-19%
23 297
+9%
22 734
-2%
23 188
+2%
Liabilities
Accounts Payable
226
223
420
657
1 131
1 021
1 040
1 127
1 204
1 120
Accrued Liabilities
106
207
288
325
1 064
537
504
625
621
648
Short-Term Debt
472
578
0
0
0
0
0
0
0
10
Current Portion of Long-Term Debt
200
300
542
0
1 385
1 359
605
865
483
75
Other Current Liabilities
384
252
409
782
3 016
2 997
2 069
1 894
1 676
1 750
Total Current Liabilities
1 388
1 560
1 658
1 764
6 596
5 914
4 217
4 512
3 984
3 603
Long-Term Debt
0
0
0
475
380
34
726
584
135
401
Deferred Income Tax
248
246
221
194
450
323
188
149
140
135
Minority Interest
69
82
42
42
12
14
5
1
3
1
Other Liabilities
80
117
44
42
1 993
569
1 086
865
522
25
Total Liabilities
1 784
N/A
2 006
+12%
1 965
-2%
2 516
+28%
9 431
+275%
6 853
-27%
6 222
-9%
6 111
-2%
4 777
-22%
4 164
-13%
Equity
Common Stock
0
0
0
1
1
1
1
1
1
1
Retained Earnings
6
208
97
599
1 638
2 871
1 497
537
1 384
2 321
Additional Paid In Capital
4 659
4 659
5 311
12 143
16 457
16 162
16 260
16 413
16 223
16 313
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
12
19
24
Other Equity
66
76
48
122
308
363
331
248
369
415
Total Equity
4 599
N/A
4 375
-5%
5 166
+18%
12 621
+144%
18 403
+46%
19 397
+5%
15 094
-22%
17 186
+14%
17 957
+4%
19 025
+6%
Total Liabilities & Equity
6 383
N/A
6 381
0%
7 132
+12%
15 137
+112%
27 835
+84%
26 250
-6%
21 316
-19%
23 297
+9%
22 734
-2%
23 188
+2%
Shares Outstanding
Common Shares Outstanding
667
667
700
906
906
1 012
1 016
1 022
1 015
1 023

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.